Clinical evaluation of narrow platform RoxolidTM implants in patients with hypodontia at 1 year

Abstract

Congenital absence of teeth, commonly known as hypodontia, has a reported prevalence of between 2 and 6%. It presents many clinical challenges, and it has a significant impact on psycho-social well being of patients. A typical presentation of mild hypodontia is shown in Figure 1. Rehabilitation of these patients with implants is complicated by small bone volume, and it requires multi-disciplinary input. Potential sites for implants in the anterior maxilla are compromised by low bone volume. A novel narrow implant made with TiZr alloy, RoxolidTM (Straumann AG), has been developed which offers the potential to place implants in these patients with minimal or no requirement for bone augmentation surgery